[1] 中华医学会内分泌学分会. 高尿酸血症和痛风治疗的中国专家共识[J]. 中国内分泌代谢杂志, 2013,29(11):913-920. [2] 秦贵军. 药源性高尿酸血症[J]. 药品评价, 2015,12(7):19-22. [3] 洪梅. 奥氮平致高尿酸血症1例[J]. 中国药物警戒, 2013,10(7):444. [4] Salem CB, Slim R, Fathallah N, et al.Drug-induced hyperuricaemiaand gout[J]. Rheumatology, 2017,56(5):679-688. [5] 周捷. 药源性高尿酸血症的治病药物及防治对策[J]. 中国现代药物应用, 2008,2(16):108-109. [6] 中国医师协会心血管内科医师分会. 无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J]. 中国临床医生,2011,39(2):73-77. [7] Bruderer S, Bodmer M, Jick SS, et al.Use of diuretics and risk of incident gout: a population-based case-control study[J]. Arthritis Rheumatol, 2014(66):185. [8] Pham AQ, Doan A, Andersen M.Pyrazinamide-induced hyperuricemia[J].PT, 2014,39(10):695-715. [9] 张海英,卓来东,李玉珍. 小剂量阿司匹林对正常小鼠及高尿酸血症模型小鼠血尿酸的影响[J]. 中国新药杂志,2009,18(5):434-436. [10] Bahn A, Hagod Y, Reuter S,et al.Identification of a newurate and high affinity nicotinate transporter, hOAT10(SLC22A13)[J]. Biol Chem,2008,283(16):332-341. [11] 袁钢,许晴晴,吴旭. 探讨质子泵抑制剂(PPIs)对痛风活动的影响机制[J]. 内蒙古中医药,2013(9):50-51. [12] 中国老年保健医学研究会老年内分泌与代谢病分会.老年人多重用药安全管理专家共识[J]. 中国糖尿病志,2018,26(9):705-717. [13] 何志钧,梁运啸,梁列新. 质子泵抑制剂治疗上消化道出血对痛风复发的影响[J]. 药物与临床,2019,32(1):154-156. [14] Perez-Ruiz F, Atxotegi J, Hernando I, et al.Using serum urate levels to determine the period free of gouty symptoms after withdrawalof long-term urate-lowering therapy: a prospective study[J]. Arthritis Rheum,2006,55(5):786-790. [15] Choi HK, Soriano LC, Zhang Y, et al.Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study[J]. BMJ, 2012(344):d8190. [16] 雷艳萍,雷金艳,雷飞燕. 抗结核药吡嗪酰胺引起继发性痛风的临床观察[J]. 中国现代医生,2010,48(10):131. [17] 李媛媛,苏东栋,哈米提·努力克. 吡嗪酰胺引起糖尿病合并肺结核患者高尿酸血症的临床观察[J]. 当代医学,2017,23(20):91-92. [18] Roos JC, Boer P, Peuker KH, et al.Changesin intrarenal uric acid handling during chronic spironolac-tone treatment in patients with essential hypertension[J].Nephron,1982,32(3):209-213. |